What we're reading

As firefighters fought blazes kindled by tinder-dry conditions on the Greek island, the authorities sent tourists and residents to boats moored

Multiple sclerosis was once seen as a “dead-end disease.” But lots of little interventions have added up to remarkable progress

A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking

The price of the pill, which has not been announced, will determine how affordable it will be when it becomes available in early 2024

Toxic chemicals were found in Indian-produced medicine that led to the deaths of dozens of children

The hottest June ever and a record-breaking start to July should be a wake-up call. We weren’t built for this.

Treatments aren’t widely tested on older patients—the very people who need them most

The assessment is the first advance in diagnosing the deadly condition since it was discovered more than a century ago, experts said

Stepping down after two and a half years, she says public needs to be wary of misinformation

Even though twenty-three African countries are dealing with unsustainable debt burdens, very few have stopped servicing their external obligations

The names of Nazi-era doctors are still found on diseases and body parts. By expunging them, will doctors forget lessons of the past?

Native leaders welcome the federal government’s move, even as they remain skeptical the effort will outlast Biden's term